Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001140361-17-020423
Filing Date
2017-05-15
Accepted
2017-05-15 12:51:44
Documents
1
Effectiveness Date
2017-05-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 12840
  Complete submission text file 0001140361-17-020423.txt   14012
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

EIN.: 273364627 | State of Incorp.: DE | Fiscal Year End: 0630
Type: D/A | Act: 33 | File No.: 021-249771 | Film No.: 17842777